David Calabrese

Title: The Innovative Contributions of David Calabrese

Introduction

David Calabrese is a prominent inventor based in Lausanne, Switzerland. He has made significant contributions to the field of biotechnology, particularly in gene expression and protein production. With a total of four patents to his name, Calabrese's work has advanced the understanding and application of genetic engineering.

Latest Patents

Calabrese's latest patents include "Enhanced transgene expression and processing," which discloses constructs and methods for expressing DNAs of interest in non-primate eukaryotic host cells. This invention highlights advantages in terms of quantity and quality of expression, including high stability and, when appropriate, the transport of the expression product out of the cell. Another notable patent is "High efficiency gene transfer and expression in mammalian cells by a multiple transfection procedure of MAR sequences." This invention relates to purified and isolated DNA sequences that enhance protein production activity, specifically through the use of matrix attachment regions (MARs) in eukaryotic cells.

Career Highlights

Calabrese is currently associated with Selexis S.A., a company known for its innovative approaches in the field of biopharmaceuticals. His work at Selexis has allowed him to explore and develop cutting-edge technologies that improve gene transfer and expression methodologies.

Collaborations

Throughout his career, Calabrese has collaborated with notable colleagues, including Nicolas Mermod and Pierre Alain Girod. These partnerships have fostered a collaborative environment that enhances research and development efforts in biotechnology.

Conclusion

David Calabrese's contributions to biotechnology through his patents and collaborative efforts have significantly impacted the field. His innovative approaches continue to pave the way for advancements in gene expression and protein production.